HEADER SUGAR BINDING PROTEIN 07-APR-14 4Q26 TITLE CRYSTAL STRUCTURE OF GALECTIN-1 IN COMPLEX WITH N-ACETYLLACTOSAMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: GALECTIN-1; COMPND 3 CHAIN: A, B, G, H; COMPND 4 SYNONYM: GAL-1, 14 KDA LAMININ-BINDING PROTEIN, HLBP14, 14 KDA COMPND 5 LECTIN, BETA-GALACTOSIDE-BINDING LECTIN L-14-I, GALAPTIN, HBL, HPL, COMPND 6 LACTOSE-BINDING LECTIN 1, LECTIN GALACTOSIDE-BINDING SOLUBLE 1, COMPND 7 PUTATIVE MAPK-ACTIVATING PROTEIN PM12, S-LAC LECTIN 1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: LGALS1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SUGAR BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR C.GRIMM,N.BERTLEFF-ZIESCHANG REVDAT 3 06-NOV-24 4Q26 1 HETSYN REVDAT 2 29-JUL-20 4Q26 1 COMPND REMARK SEQADV HET REVDAT 2 2 1 HETNAM HETSYN FORMUL LINK REVDAT 2 3 1 SITE ATOM REVDAT 1 07-OCT-15 4Q26 0 JRNL AUTH C.GRIMM,N.BERTLEFF-ZIESCHANG JRNL TITL CRYSTAL STRUCTURE OF GALECTIN-1 IN COMPLEX WITH JRNL TITL 2 N-ACETYLLACTOSAMINE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.7.1_743) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.02 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.990 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 129632 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.163 REMARK 3 R VALUE (WORKING SET) : 0.162 REMARK 3 FREE R VALUE : 0.203 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 1.540 REMARK 3 FREE R VALUE TEST SET COUNT : 2000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.0511 - 3.3709 0.93 8964 141 0.1809 0.2063 REMARK 3 2 3.3709 - 2.6757 1.00 9315 145 0.1483 0.1730 REMARK 3 3 2.6757 - 2.3375 1.00 9270 146 0.1495 0.1845 REMARK 3 4 2.3375 - 2.1237 1.00 9190 144 0.1268 0.2047 REMARK 3 5 2.1237 - 1.9715 1.00 9184 144 0.1245 0.1752 REMARK 3 6 1.9715 - 1.8553 1.00 9163 143 0.1241 0.1757 REMARK 3 7 1.8553 - 1.7624 1.00 9153 144 0.1329 0.1816 REMARK 3 8 1.7624 - 1.6856 1.00 9147 143 0.1442 0.2225 REMARK 3 9 1.6856 - 1.6207 1.00 9075 142 0.1574 0.2257 REMARK 3 10 1.6207 - 1.5648 1.00 9140 143 0.1729 0.2484 REMARK 3 11 1.5648 - 1.5159 1.00 9105 143 0.2000 0.2333 REMARK 3 12 1.5159 - 1.4725 1.00 9063 142 0.2442 0.2684 REMARK 3 13 1.4725 - 1.4338 1.00 9130 143 0.2836 0.3342 REMARK 3 14 1.4338 - 1.3990 0.96 8733 137 0.3656 0.3976 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.43 REMARK 3 B_SOL : 45.46 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.320 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.620 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.48560 REMARK 3 B22 (A**2) : 4.44180 REMARK 3 B33 (A**2) : -1.95620 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.018 4519 REMARK 3 ANGLE : 2.023 6158 REMARK 3 CHIRALITY : 0.132 689 REMARK 3 PLANARITY : 0.010 819 REMARK 3 DIHEDRAL : 19.827 1696 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4Q26 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-APR-14. REMARK 100 THE DEPOSITION ID IS D_1000085509. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M-F REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 129682 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.399 REMARK 200 RESOLUTION RANGE LOW (A) : 48.023 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 16.700 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.09200 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.15 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.74 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 33.19200 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.75850 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.19200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.75850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: G, H, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: G, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: H, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH B 399 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 MET A 0 REMARK 465 ALA A 1 REMARK 465 GLY B -1 REMARK 465 MET B 0 REMARK 465 ALA B 1 REMARK 465 GLY G -1 REMARK 465 MET G 0 REMARK 465 ALA G 1 REMARK 465 GLY H -1 REMARK 465 MET H 0 REMARK 465 ALA H 1 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 CYS A 2 SG REMARK 470 CYS B 2 SG REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HH22 ARG G 18 O HOH G 429 1.05 REMARK 500 HH21 ARG G 18 O HOH G 331 1.48 REMARK 500 H ALA A 75 O HOH A 425 1.56 REMARK 500 HZ1 LYS H 127 O HOH H 347 1.58 REMARK 500 OE2 GLU G 71 HO3 NDG E 1 1.58 REMARK 500 O HOH G 431 O HOH G 432 1.81 REMARK 500 NH2 ARG G 18 O HOH G 429 1.85 REMARK 500 O GLY G 82 O HOH G 433 1.86 REMARK 500 O HOH A 356 O HOH A 408 1.89 REMARK 500 OE1 GLU A 74 O HOH A 406 1.89 REMARK 500 O HOH H 329 O HOH H 340 1.91 REMARK 500 OD1 ASN B 50 O HOH B 386 1.92 REMARK 500 O HOH G 308 O HOH G 406 1.93 REMARK 500 O HOH B 402 O HOH B 409 1.94 REMARK 500 O HOH A 397 O HOH A 422 1.94 REMARK 500 O HOH G 360 O HOH G 430 1.94 REMARK 500 N ASN G 113 O HOH G 408 1.97 REMARK 500 O HOH A 365 O HOH A 388 2.01 REMARK 500 O HIS G 52 O HOH G 330 2.02 REMARK 500 OD2 ASP H 102 O HOH H 366 2.05 REMARK 500 O HOH A 329 O HOH A 417 2.05 REMARK 500 OD1 ASP G 123 O HOH G 390 2.07 REMARK 500 O HOH G 385 O HOH G 414 2.08 REMARK 500 O HOH G 378 O HOH G 409 2.09 REMARK 500 O HOH H 401 O HOH H 403 2.12 REMARK 500 O HOH H 377 O HOH H 385 2.12 REMARK 500 N CYS B 2 O HOH B 380 2.12 REMARK 500 O LEU G 114 O HOH G 424 2.15 REMARK 500 O HOH G 411 O HOH H 359 2.15 REMARK 500 O HOH G 398 O HOH G 399 2.17 REMARK 500 CA ASN G 113 O HOH G 408 2.18 REMARK 500 O HOH A 428 O HOH A 431 2.18 REMARK 500 O HOH A 381 O HOH A 414 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NH2 ARG H 20 O HOH H 321 4455 0.72 REMARK 500 HH22 ARG H 20 O HOH H 321 4455 0.95 REMARK 500 HB1 ALA A 75 HB3 ASP G 102 1655 1.33 REMARK 500 CZ ARG H 20 O HOH H 321 4455 1.33 REMARK 500 HH21 ARG H 20 O HOH H 321 4455 1.40 REMARK 500 O HOH A 375 O HOH B 361 4554 1.96 REMARK 500 NH1 ARG H 20 O HOH H 321 4455 2.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ASP G 123 C ASP G 123 O 0.117 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PHE A 133 N - CA - C ANGL. DEV. = -16.4 DEGREES REMARK 500 LEU B 9 CB - CG - CD1 ANGL. DEV. = -10.8 DEGREES REMARK 500 ASP G 125 CB - CG - OD2 ANGL. DEV. = 5.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 50 93.96 -162.74 REMARK 500 PHE A 133 79.71 -116.49 REMARK 500 PHE B 77 82.18 -150.45 REMARK 500 PRO B 78 48.09 -94.12 REMARK 500 PRO G 78 53.19 -93.16 REMARK 500 PHE G 133 69.50 -114.25 REMARK 500 ASP H 26 -2.59 71.75 REMARK 500 ASN H 50 88.56 -156.39 REMARK 500 ASN H 56 59.07 36.71 REMARK 500 PRO H 78 51.90 -90.86 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASP G 123 GLY G 124 125.89 REMARK 500 PHE G 133 ASP G 134 -136.65 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4Q1P RELATED DB: PDB REMARK 900 RELATED ID: 4Q1R RELATED DB: PDB REMARK 900 RELATED ID: 4Q27 RELATED DB: PDB REMARK 900 RELATED ID: 4Q2F RELATED DB: PDB DBREF 4Q26 A 0 134 UNP P09382 LEG1_HUMAN 1 135 DBREF 4Q26 B 0 134 UNP P09382 LEG1_HUMAN 1 135 DBREF 4Q26 G 0 134 UNP P09382 LEG1_HUMAN 1 135 DBREF 4Q26 H 0 134 UNP P09382 LEG1_HUMAN 1 135 SEQADV 4Q26 GLY A -1 UNP P09382 EXPRESSION TAG SEQADV 4Q26 GLY B -1 UNP P09382 EXPRESSION TAG SEQADV 4Q26 GLY G -1 UNP P09382 EXPRESSION TAG SEQADV 4Q26 GLY H -1 UNP P09382 EXPRESSION TAG SEQRES 1 A 136 GLY MET ALA CYS GLY LEU VAL ALA SER ASN LEU ASN LEU SEQRES 2 A 136 LYS PRO GLY GLU CME LEU ARG VAL ARG GLY GLU VAL ALA SEQRES 3 A 136 PRO ASP ALA LYS SER PHE VAL LEU ASN LEU GLY LYS ASP SEQRES 4 A 136 SER ASN ASN LEU CYS LEU HIS PHE ASN PRO ARG PHE ASN SEQRES 5 A 136 ALA HIS GLY ASP ALA ASN THR ILE VAL CYS ASN SER LYS SEQRES 6 A 136 ASP GLY GLY ALA TRP GLY THR GLU GLN ARG GLU ALA VAL SEQRES 7 A 136 PHE PRO PHE GLN PRO GLY SER VAL ALA GLU VAL CME ILE SEQRES 8 A 136 THR PHE ASP GLN ALA ASN LEU THR VAL LYS LEU PRO ASP SEQRES 9 A 136 GLY TYR GLU PHE LYS PHE PRO ASN ARG LEU ASN LEU GLU SEQRES 10 A 136 ALA ILE ASN TYR MET ALA ALA ASP GLY ASP PHE LYS ILE SEQRES 11 A 136 LYS CME VAL ALA PHE ASP SEQRES 1 B 136 GLY MET ALA CYS GLY LEU VAL ALA SER ASN LEU ASN LEU SEQRES 2 B 136 LYS PRO GLY GLU CME LEU ARG VAL ARG GLY GLU VAL ALA SEQRES 3 B 136 PRO ASP ALA LYS SER PHE VAL LEU ASN LEU GLY LYS ASP SEQRES 4 B 136 SER ASN ASN LEU CYS LEU HIS PHE ASN PRO ARG PHE ASN SEQRES 5 B 136 ALA HIS GLY ASP ALA ASN THR ILE VAL CYS ASN SER LYS SEQRES 6 B 136 ASP GLY GLY ALA TRP GLY THR GLU GLN ARG GLU ALA VAL SEQRES 7 B 136 PHE PRO PHE GLN PRO GLY SER VAL ALA GLU VAL CME ILE SEQRES 8 B 136 THR PHE ASP GLN ALA ASN LEU THR VAL LYS LEU PRO ASP SEQRES 9 B 136 GLY TYR GLU PHE LYS PHE PRO ASN ARG LEU ASN LEU GLU SEQRES 10 B 136 ALA ILE ASN TYR MET ALA ALA ASP GLY ASP PHE LYS ILE SEQRES 11 B 136 LYS CME VAL ALA PHE ASP SEQRES 1 G 136 GLY MET ALA CYS GLY LEU VAL ALA SER ASN LEU ASN LEU SEQRES 2 G 136 LYS PRO GLY GLU CME LEU ARG VAL ARG GLY GLU VAL ALA SEQRES 3 G 136 PRO ASP ALA LYS SER PHE VAL LEU ASN LEU GLY LYS ASP SEQRES 4 G 136 SER ASN ASN LEU CYS LEU HIS PHE ASN PRO ARG PHE ASN SEQRES 5 G 136 ALA HIS GLY ASP ALA ASN THR ILE VAL CYS ASN SER LYS SEQRES 6 G 136 ASP GLY GLY ALA TRP GLY THR GLU GLN ARG GLU ALA VAL SEQRES 7 G 136 PHE PRO PHE GLN PRO GLY SER VAL ALA GLU VAL CME ILE SEQRES 8 G 136 THR PHE ASP GLN ALA ASN LEU THR VAL LYS LEU PRO ASP SEQRES 9 G 136 GLY TYR GLU PHE LYS PHE PRO ASN ARG LEU ASN LEU GLU SEQRES 10 G 136 ALA ILE ASN TYR MET ALA ALA ASP GLY ASP PHE LYS ILE SEQRES 11 G 136 LYS CME VAL ALA PHE ASP SEQRES 1 H 136 GLY MET ALA CYS GLY LEU VAL ALA SER ASN LEU ASN LEU SEQRES 2 H 136 LYS PRO GLY GLU CME LEU ARG VAL ARG GLY GLU VAL ALA SEQRES 3 H 136 PRO ASP ALA LYS SER PHE VAL LEU ASN LEU GLY LYS ASP SEQRES 4 H 136 SER ASN ASN LEU CYS LEU HIS PHE ASN PRO ARG PHE ASN SEQRES 5 H 136 ALA HIS GLY ASP ALA ASN THR ILE VAL CYS ASN SER LYS SEQRES 6 H 136 ASP GLY GLY ALA TRP GLY THR GLU GLN ARG GLU ALA VAL SEQRES 7 H 136 PHE PRO PHE GLN PRO GLY SER VAL ALA GLU VAL CME ILE SEQRES 8 H 136 THR PHE ASP GLN ALA ASN LEU THR VAL LYS LEU PRO ASP SEQRES 9 H 136 GLY TYR GLU PHE LYS PHE PRO ASN ARG LEU ASN LEU GLU SEQRES 10 H 136 ALA ILE ASN TYR MET ALA ALA ASP GLY ASP PHE LYS ILE SEQRES 11 H 136 LYS CME VAL ALA PHE ASP MODRES 4Q26 CME A 16 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 4Q26 CME A 88 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 4Q26 CME A 130 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 4Q26 CME B 16 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 4Q26 CME B 88 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 4Q26 CME B 130 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 4Q26 CME G 16 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 4Q26 CME G 88 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 4Q26 CME G 130 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 4Q26 CME H 16 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 4Q26 CME H 88 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE MODRES 4Q26 CME H 130 CYS S,S-(2-HYDROXYETHYL)THIOCYSTEINE HET CME A 16 10 HET CME A 88 10 HET CME A 130 10 HET CME B 16 10 HET CME B 88 10 HET CME B 130 10 HET CME G 16 10 HET CME G 88 10 HET CME G 130 10 HET CME H 16 10 HET CME H 88 10 HET CME H 130 10 HET NDG C 1 29 HET GAL C 2 22 HET NDG D 1 29 HET GAL D 2 22 HET NDG E 1 29 HET GAL E 2 22 HET NDG F 1 29 HET GAL F 2 22 HET GOL G 201 14 HETNAM CME S,S-(2-HYDROXYETHYL)THIOCYSTEINE HETNAM NDG 2-ACETAMIDO-2-DEOXY-ALPHA-D-GLUCOPYRANOSE HETNAM GAL BETA-D-GALACTOPYRANOSE HETNAM GOL GLYCEROL HETSYN NDG N-ACETYL-ALPHA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY- HETSYN 2 NDG ALPHA-D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2- HETSYN 3 NDG ACETAMIDO-2-DEOXY-GLUCOSE; 2-(ACETYLAMINO)-2-DEOXY-A- HETSYN 4 NDG D-GLUCOPYRANOSE HETSYN GAL BETA-D-GALACTOSE; D-GALACTOSE; GALACTOSE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 CME 12(C5 H11 N O3 S2) FORMUL 5 NDG 4(C8 H15 N O6) FORMUL 5 GAL 4(C6 H12 O6) FORMUL 9 GOL C3 H8 O3 FORMUL 10 HOH *495(H2 O) SHEET 1 A12 ALA A 67 TRP A 68 0 SHEET 2 A12 ASP A 54 ASP A 64 -1 N ASP A 64 O ALA A 67 SHEET 3 A12 ASN A 40 ALA A 51 -1 N HIS A 44 O ASN A 61 SHEET 4 A12 LEU A 32 ASP A 37 -1 N LYS A 36 O ASN A 40 SHEET 5 A12 ILE A 117 ALA A 122 -1 O ALA A 121 N ASN A 33 SHEET 6 A12 VAL A 5 LEU A 11 -1 N ALA A 6 O MET A 120 SHEET 7 A12 VAL B 5 LEU B 11 -1 O SER B 7 N VAL A 5 SHEET 8 A12 ILE B 117 ALA B 122 -1 O MET B 120 N ALA B 6 SHEET 9 A12 LEU B 32 ASP B 37 -1 N ASN B 33 O ALA B 121 SHEET 10 A12 ASN B 40 ALA B 51 -1 O PHE B 45 N LEU B 32 SHEET 11 A12 ASP B 54 ASP B 64 -1 O ASN B 61 N HIS B 44 SHEET 12 A12 ALA B 67 TRP B 68 -1 O ALA B 67 N ASP B 64 SHEET 1 B12 GLN A 72 ARG A 73 0 SHEET 2 B12 ASP A 54 ASP A 64 -1 N CYS A 60 O GLN A 72 SHEET 3 B12 ASN A 40 ALA A 51 -1 N HIS A 44 O ASN A 61 SHEET 4 B12 LEU A 32 ASP A 37 -1 N LYS A 36 O ASN A 40 SHEET 5 B12 ILE A 117 ALA A 122 -1 O ALA A 121 N ASN A 33 SHEET 6 B12 VAL A 5 LEU A 11 -1 N ALA A 6 O MET A 120 SHEET 7 B12 VAL B 5 LEU B 11 -1 O SER B 7 N VAL A 5 SHEET 8 B12 ILE B 117 ALA B 122 -1 O MET B 120 N ALA B 6 SHEET 9 B12 LEU B 32 ASP B 37 -1 N ASN B 33 O ALA B 121 SHEET 10 B12 ASN B 40 ALA B 51 -1 O PHE B 45 N LEU B 32 SHEET 11 B12 ASP B 54 ASP B 64 -1 O ASN B 61 N HIS B 44 SHEET 12 B12 GLN B 72 ARG B 73 -1 O GLN B 72 N CYS B 60 SHEET 1 C10 GLU A 105 PRO A 109 0 SHEET 2 C10 ASN A 95 LYS A 99 -1 N LEU A 96 O PHE A 108 SHEET 3 C10 VAL A 84 PHE A 91 -1 N CME A 88 O LYS A 99 SHEET 4 C10 LEU A 17 VAL A 23 -1 N LEU A 17 O ILE A 89 SHEET 5 C10 PHE A 126 PHE A 133 -1 O LYS A 129 N ARG A 20 SHEET 6 C10 PHE B 126 ASP B 134 -1 O LYS B 129 N PHE A 133 SHEET 7 C10 CME B 16 VAL B 23 -1 N ARG B 20 O LYS B 129 SHEET 8 C10 VAL B 84 PHE B 91 -1 O ALA B 85 N GLY B 21 SHEET 9 C10 ASN B 95 LYS B 99 -1 O LYS B 99 N CME B 88 SHEET 10 C10 GLU B 105 PRO B 109 -1 O PHE B 108 N LEU B 96 SHEET 1 D12 ALA G 67 TRP G 68 0 SHEET 2 D12 ASP G 54 ASP G 64 -1 N ASP G 64 O ALA G 67 SHEET 3 D12 ASN G 40 ALA G 51 -1 N ARG G 48 O THR G 57 SHEET 4 D12 VAL G 31 ASP G 37 -1 N LYS G 36 O ASN G 40 SHEET 5 D12 ILE G 117 ASP G 123 -1 O ALA G 121 N ASN G 33 SHEET 6 D12 VAL G 5 LEU G 11 -1 N ALA G 6 O MET G 120 SHEET 7 D12 VAL H 5 SER H 7 -1 O SER H 7 N VAL G 5 SHEET 8 D12 TYR H 119 ALA H 122 -1 O MET H 120 N ALA H 6 SHEET 9 D12 LEU H 32 ASP H 37 -1 N ASN H 33 O ALA H 121 SHEET 10 D12 ASN H 40 ALA H 51 -1 O ASN H 40 N LYS H 36 SHEET 11 D12 ASP H 54 ASP H 64 -1 O ASN H 61 N HIS H 44 SHEET 12 D12 ALA H 67 TRP H 68 -1 O ALA H 67 N ASP H 64 SHEET 1 E12 GLN G 72 GLU G 74 0 SHEET 2 E12 ASP G 54 ASP G 64 -1 N CYS G 60 O GLN G 72 SHEET 3 E12 ASN G 40 ALA G 51 -1 N ARG G 48 O THR G 57 SHEET 4 E12 VAL G 31 ASP G 37 -1 N LYS G 36 O ASN G 40 SHEET 5 E12 ILE G 117 ASP G 123 -1 O ALA G 121 N ASN G 33 SHEET 6 E12 VAL G 5 LEU G 11 -1 N ALA G 6 O MET G 120 SHEET 7 E12 VAL H 5 SER H 7 -1 O SER H 7 N VAL G 5 SHEET 8 E12 TYR H 119 ALA H 122 -1 O MET H 120 N ALA H 6 SHEET 9 E12 LEU H 32 ASP H 37 -1 N ASN H 33 O ALA H 121 SHEET 10 E12 ASN H 40 ALA H 51 -1 O ASN H 40 N LYS H 36 SHEET 11 E12 ASP H 54 ASP H 64 -1 O ASN H 61 N HIS H 44 SHEET 12 E12 GLN H 72 GLU H 74 -1 O GLN H 72 N CYS H 60 SHEET 1 F10 GLU G 105 PRO G 109 0 SHEET 2 F10 ASN G 95 LYS G 99 -1 N LEU G 96 O PHE G 108 SHEET 3 F10 SER G 83 PHE G 91 -1 N CME G 88 O LYS G 99 SHEET 4 F10 LEU G 17 VAL G 23 -1 N LEU G 17 O ILE G 89 SHEET 5 F10 PHE G 126 PHE G 133 -1 O LYS G 127 N GLU G 22 SHEET 6 F10 PHE H 126 ASP H 134 -1 O PHE H 133 N LYS G 129 SHEET 7 F10 CME H 16 VAL H 23 -1 N CME H 16 O ASP H 134 SHEET 8 F10 VAL H 84 PHE H 91 -1 O ALA H 85 N GLY H 21 SHEET 9 F10 ASN H 95 LYS H 99 -1 O LYS H 99 N CME H 88 SHEET 10 F10 GLU H 105 PRO H 109 -1 O PHE H 108 N LEU H 96 LINK C GLU A 15 N CME A 16 1555 1555 1.33 LINK C CME A 16 N LEU A 17 1555 1555 1.32 LINK C AVAL A 87 N CME A 88 1555 1555 1.32 LINK C BVAL A 87 N CME A 88 1555 1555 1.31 LINK C CME A 88 N ILE A 89 1555 1555 1.33 LINK C LYS A 129 N CME A 130 1555 1555 1.33 LINK C CME A 130 N AVAL A 131 1555 1555 1.32 LINK C CME A 130 N BVAL A 131 1555 1555 1.32 LINK C GLU B 15 N CME B 16 1555 1555 1.33 LINK C CME B 16 N LEU B 17 1555 1555 1.31 LINK C AVAL B 87 N CME B 88 1555 1555 1.33 LINK C BVAL B 87 N CME B 88 1555 1555 1.33 LINK C CME B 88 N ILE B 89 1555 1555 1.34 LINK C LYS B 129 N CME B 130 1555 1555 1.37 LINK C CME B 130 N VAL B 131 1555 1555 1.32 LINK C GLU G 15 N CME G 16 1555 1555 1.34 LINK C CME G 16 N LEU G 17 1555 1555 1.34 LINK C AVAL G 87 N CME G 88 1555 1555 1.33 LINK C BVAL G 87 N CME G 88 1555 1555 1.32 LINK C CME G 88 N ILE G 89 1555 1555 1.33 LINK C LYS G 129 N CME G 130 1555 1555 1.33 LINK C CME G 130 N AVAL G 131 1555 1555 1.33 LINK C CME G 130 N BVAL G 131 1555 1555 1.33 LINK C GLU H 15 N CME H 16 1555 1555 1.33 LINK C CME H 16 N LEU H 17 1555 1555 1.32 LINK C AVAL H 87 N CME H 88 1555 1555 1.33 LINK C BVAL H 87 N CME H 88 1555 1555 1.34 LINK C CME H 88 N ILE H 89 1555 1555 1.32 LINK C LYS H 129 N CME H 130 1555 1555 1.35 LINK C CME H 130 N AVAL H 131 1555 1555 1.32 LINK C CME H 130 N BVAL H 131 1555 1555 1.33 LINK O4 NDG C 1 C1 GAL C 2 1555 1555 1.47 LINK O4 NDG D 1 C1 GAL D 2 1555 1555 1.41 LINK O4 NDG E 1 C1 GAL E 2 1555 1555 1.47 LINK O4 NDG F 1 C1 GAL F 2 1555 1555 1.38 CRYST1 66.384 85.517 116.076 90.00 90.00 90.00 P 21 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015064 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011694 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008615 0.00000